Is ribavirin actually useful for Genotype 1 cirrhotic patients who receive DAAs combination? An updated meta-analysis of randomized controlled trials - Lipides Nutrition Cancer - UMR866 Accéder directement au contenu
Article Dans Une Revue Hepatology Année : 2015

Is ribavirin actually useful for Genotype 1 cirrhotic patients who receive DAAs combination? An updated meta-analysis of randomized controlled trials

Fichier non déposé

Dates et versions

hal-03946474 , version 1 (19-01-2023)

Identifiants

  • HAL Id : hal-03946474 , version 1

Citer

Vincent Di Martino, Carine Richou, Jean Paul Cervoni, Delphine Weil, Claire Vanlemmens, et al.. Is ribavirin actually useful for Genotype 1 cirrhotic patients who receive DAAs combination? An updated meta-analysis of randomized controlled trials. Hepatology, 2015, 62 (1, SI), pp.796A-797A. ⟨hal-03946474⟩
10 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More